Werewolf Therapeutics News and Activities

Werewolf Therapeutics is a company listed under the stock ticker HOWL (US).

View the org chart displaying its 24 main executives

Most searched biographies at Werewolf Therapeutics

• Dan Hicklin, President, Chief Executive Officer and Director
• Briggs Morrison, Director
• Alon Lazarus, Director

Create your alert
to follow the executive moves at Werewolf Therapeutics.

Werewolf Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Werewolf Therapeutics

• News & Events | Werewolf Therapeutics Inc.
• PRESS RELEASE: Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines - Werewolf Therapeutics

Social media about Werewolf Therapeutics

• Werewolf Therapeutics on Wikipedia, Google News & Yahoo Finance
• Werewolf Therapeutics on LinkedIn, X (Twitter) & YouTube